Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 253 results for "glenmark pharmaceuticals"

Glenmark Pharma Q3 PAT seen up 37% to Rs 310 cr: HDFC Securities

Net Sales are expected to increase by 0.9 percent Q-o-Q (down 27.1 percent Y-o-Y) to Rs 2190 crore, according to HDFC Securities. Money Control, 1 week ago

29 images for glenmark pharmaceuticals, 1 week ago, 2 weeks ago
Hindu Business Line, 2 weeks ago
Pharmacy Times, 2 weeks ago
Pharmaceutical, 4 weeks ago
Financial Express, 1 month ago, 2 months ago, 2 months ago
DNA, 3 months ago
India Infoline, 2 months ago

Glenmark's blood pressure drug gets US FDA nod; shares up 1%

The US drug regulator gave a tentative nod for the company's Olmesartan Medoxomil tablets, which is used to treat blood pressure.
 Money Control5 days ago GLENMARK PHARMACEUTICALS : Receives FDA Clearance of IND for GBR 1302-BEAT Phase I Trial  4 Traders1 week ago Glenmark gets USFDA approval for capsules treating leukemia; stocks up 1.2%  India Infoline2 weeks ago Glenmark Pharmaceuticals Receives FDA Clearance of IND for GBR 1302-BEAT„¢ Phase I Trial  TickerTech.com2 weeks ago

Glenmark Pharmaceuticals Q3 results on Feb 02, 2017

Glenmark Pharmaceuticals' board meeting will be held on February 02, 2017, to consider and approve the Company's Unaudited Financial Statements for the Third Quarter and Nine months ended December 31, 2016 (Q3). Further, as per the
 Money Control6 days ago Glenmark Pharmaceuticals Ltd to consider Q3 results on Feb 02, 2017  Equity Bulls6 days ago

BRIEF-Glenmark Pharmaceuticals sees revenues to grow at a CAGR of 15-20 pct over next 5 years

n"Jan 10 Glenmark Pharmaceuticals Ltd * Says POC study ongoing in USA and Canada in adults with moderate-to-severe ad for GBR 830; expect to complete by q3 cy17 * Says phase 1 part 1 dose escalation study currently underway in her2+ subjects for ...
 Reuters India1 week ago
India Infoline

Glenmark Pharma gets tentative US FDA nod

The Indian markets on January 19 opened in red, however, at9.26 amthe Sensex is trading at 27283.23, up by 25.59 points.
 India Infoline5 days ago Pharma stocks drop on Trump's rhetoric on drug pricing  KJMC Group1 week ago Live Stock Market Updates - Nifty shuts above 8,350 mark; Metal index lead  India Infoline1 week ago Live Stock Market Updates - Sensex, Nifty flat; Realty, IT stocks lead  India Infoline2 weeks ago

Global Linezolid Market 2016 - Pfizer, Daewoong, Glenmark, Optimus, Symed Labs, Amoli, Runzhong Pharma

Global Linezolid Market Outlook 2016-2021 This press release was orginally distributed by SBWire Deerfield Beach, FL -- ( SBWIRE ) -- 01/10/2017 -- Linezolid is an antibiotic used for the treatment of serious infections caused by Gram-positive ...
 Digital Journal1 week ago Psychosis Market Report Overview, Mechanism and Development by Companies 2016  Before It's News3 weeks ago Keratoacanthoma Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 - 2022  Before It's News3 weeks ago Global Botanical And Plant Drugs Market is expected to grow at… month ago

Q3 earnings for pharma sector: A potpourri amid US pricing woes

For pharma sector as a whole, analysts expect sales growth of 8-11% during the third quarter Mumbai: The December quarter is likely to be a mixed bag for pharmaceutical industry with pricing pressure and lack of meaningful product approvals in the ...
 Livemint.com4 hours ago

While metal stocks shine, few pharma names turn attractive

While metal stocks have been buzzing on Dalal Street amid a spike in base metal prices on expectation of better demand due to higher infrastructure spend by the Donald Trump administration in the US, another counter has thrown up an attractive ...
 Economic Times6 hours ago
Asian Lite

Pharma stocks come under selling pressure as worries mount over Trump plans

Pharma stocks continued to face selling pressure as investors worried over the impact of the Trump administration’s plans to curb drug prices in the US offloaded the stocks. Most of the top pharma stocks fell by 1-4 per cent even on a day when broader ...
 The Financial Chronicle17 hours ago Trump's drug cost concern an opportunity for Indian firms  Financial Chronicle1 day ago Trump presidency: Experts prefer to stay in 'no-action' mode  Smart Investor4 days ago At Press Conference, Trump Raises Issue of Pharma Overcharging That Could Impact India  India-West1 week ago

2017 going to be a bottom-up year: Rajesh Kothari

In a chat with , Rajesh Kothari, CIO, AlfAccurate Advisors, says if he can get any company with a reasonable valuation with ingredients that you are looking for, he will go for it. Edited excerpts: I am looking at your top holdings. From amongst ...
 Economic Times1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less